0000899243-20-009409.txt : 20200325
0000899243-20-009409.hdr.sgml : 20200325
20200325170021
ACCESSION NUMBER: 0000899243-20-009409
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200323
FILED AS OF DATE: 20200325
DATE AS OF CHANGE: 20200325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robinson James A. Jr.
CENTRAL INDEX KEY: 0001734295
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 20742923
MAIL ADDRESS:
STREET 1: 852 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Urovant Sciences Ltd.
CENTRAL INDEX KEY: 0001740547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
BUSINESS PHONE: 949-226-6029
MAIL ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-23
0
0001740547
Urovant Sciences Ltd.
UROV
0001734295
Robinson James A. Jr.
C/O UROVANT SCIENCES, INC.
5281 CALIFORNIA AVENUE, SUITE 100
IRVINE
CA
92617
1
1
0
0
PEO;CEO/Urovant Sciences, Inc.
Stock Appreciation Right (Right to Buy)
9.16
2020-03-23
4
A
0
845732
0.00
A
2030-03-22
Common Shares
845732
845732
D
25% of the stock appreciation rights ("SARs") shall vest and become exercisable on March 23, 2021; the remaining SARs vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
The SARs may be settled in cash or in the Issuer's common shares.
/s/ Bryan Smith, Attorney-in-Fact
2020-03-25